ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36535
0.00%
Bitcoin
67,653.21
0.25%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Singular Genomics Systems Inc (OMIC)

  7. Singular Genomics Systems Inc (OMIC) News

OMIC

Singular Genomics Systems (OMIC)

Singular Genomics Systems Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OMIC
DateTimeSourceHeadlineSymbolCompany
05/31/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
05/30/20243:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMICSingular Genomics Systems Inc
05/29/20243:05PMGlobeNewswire Inc.Singular Genomics to Present at the Goldman Sachs Global Healthcare ConferenceNASDAQ:OMICSingular Genomics Systems Inc
05/14/20243:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMICSingular Genomics Systems Inc
05/14/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMICSingular Genomics Systems Inc
05/14/20243:05PMGlobeNewswire Inc.Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial ResultsNASDAQ:OMICSingular Genomics Systems Inc
05/13/20246:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
05/13/20246:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
05/13/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
05/13/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
05/01/20243:05PMGlobeNewswire Inc.Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:OMICSingular Genomics Systems Inc
03/18/20243:05PMGlobeNewswire Inc.Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:OMICSingular Genomics Systems Inc
03/04/20243:05PMGlobeNewswire Inc.Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024NASDAQ:OMICSingular Genomics Systems Inc
02/14/20243:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OMICSingular Genomics Systems Inc
02/14/20243:15PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OMICSingular Genomics Systems Inc
02/13/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
02/13/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
02/13/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
02/13/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
02/13/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
02/05/20249:55AMGlobeNewswire Inc.Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing PlatformNASDAQ:OMICSingular Genomics Systems Inc
02/05/20249:54AMGlobeNewswire Inc.Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic AnalysisNASDAQ:OMICSingular Genomics Systems Inc
01/19/20243:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMICSingular Genomics Systems Inc
01/08/20245:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMICSingular Genomics Systems Inc
01/07/20244:00PMGlobeNewswire Inc.Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 RevenueNASDAQ:OMICSingular Genomics Systems Inc
12/18/20234:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
12/18/20234:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
12/18/20234:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
12/18/20234:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
11/20/20233:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMICSingular Genomics Systems Inc
 Showing the most relevant articles for your search:NASDAQ:OMIC

Your Recent History

COIN
ENKEUR
BOV
PETRK309
PETRK309 Ex:28,09
BIT
P1Z356
NLBNPIT1Z356 20991231 17...
BIT
P1UQ32
NLBNPIT1UQ32 20351221 29...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved